Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease

Abstract Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson’s disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian...

Full description

Bibliographic Details
Main Authors:	Toshiki Tezuka, Daisuke Taniguchi, Mariko Sano, Tomoyo Shimada, Yutaka Oji, Taiji Tsunemi, Aya Ikeda, Yuanzhe Li, Hiroyo Yoshino, Jun Ogata, Kahori Shiba-Fukushima, Manabu Funayama, Kenya Nishioka, Yuzuru Imai, Nobutaka Hattori
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-08-01
Series:	npj Parkinson's Disease
Online Access:	https://doi.org/10.1038/s41531-022-00367-y

Similar Items

A Novel LRRK2 Variant p.G2294R in the WD40 Domain Identified in Familial Parkinson’s Disease Affects LRRK2 Protein Levels
by: Jun Ogata, et al.
Published: (2021-04-01)

Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies
by: Kenya Nishioka, et al.
Published: (2022-06-01)

A complex form of hereditary spastic paraplegia harboring a novel variant, p.W1515*, in the SPG11 gene
by: Kensuke Daida, et al.
Published: (2022-03-01)

2385
by: Laura Camarata, et al.
Published: (2017-09-01)

PINK1-mediated phosphorylation of Parkin boosts Parkin activity in Drosophila.
by: Kahori Shiba-Fukushima, et al.
Published: (2014-06-01)

A case of chronic progressive external ophthalmoplegia presenting with central neurogenic hyperventilation
by: Mariko Sano, et al.
Published: (2022-12-01)

Curcumin Reduced H2O2- and G2385R-LRRK2-Induced Neurodegeneration
by: Jinru Zhang, et al.
Published: (2021-10-01)

Is Glial Dysfunction the Key Pathogenesis of <i>LRRK2</i>-Linked Parkinson’s Disease?
by: Tatou Iseki, et al.
Published: (2023-01-01)

Generation of three clones (JUCGRMi002-A, B, C) of induced pluripotent stem cells from a Parkinson’s disease patient with SNCA duplication
by: Kei-ichi Ishikawa, et al.
Published: (2024-02-01)

Reduced TDP-43 Expression Improves Neuronal Activities in a Drosophila Model of Perry Syndrome
by: Yuka Hosaka, et al.
Published: (2017-07-01)

Effect of LRRK2 G2385R Variant on Subthalamic Deep Brain Stimulation Efficacy in Parkinson's Disease in a Han Chinese Population
by: Si Chen, et al.
Published: (2019-11-01)

A patient clinically diagnosed as multiple system atrophy harboring LRRK2 p.G2019S
by: Shoichiro Ando, et al.
Published: (2019-01-01)

Parkinson disease-associated Leucine-rich repeat kinase regulates UNC-104-dependent axonal transport of Arl8-positive vesicles in Drosophila
by: Tsuyoshi Inoshita, et al.
Published: (2022-12-01)

A Cell-Based High-Throughput Screening Identified Two Compounds that Enhance PINK1-Parkin Signaling
by: Kahori Shiba-Fukushima, et al.
Published: (2020-05-01)

The LRRK2 G2385R variant is a partial loss-of-function mutation that affects synaptic vesicle trafficking through altered protein interactions
by: Maria Dolores Perez Carrion, et al.
Published: (2017-07-01)

Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant
by: Yu-Che Cheng, et al.
Published: (2018-04-01)

Loss of Parkinson’s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c
by: Hongrui Meng, et al.
Published: (2017-06-01)

Generation of three hiPSC clones from a Parkinson’s disease patient with a heterozygous variant of VPS35 p.D620N
by: Kei-ichi Ishikawa, et al.
Published: (2022-04-01)

2385 Role of the antioxidant enzyme catalase in respiratory syncytial virus infection
by: Maria Ansar, et al.
Published: (2018-06-01)

v.40, n.11, p.2385.2388, nov, 2010
by: Marcos Fernando Basso, et al.
Published: (2011-02-01)

Phosphorylation of mitochondrial polyubiquitin by PINK1 promotes Parkin mitochondrial tethering.
by: Kahori Shiba-Fukushima, et al.
Published: (2014-12-01)

Neurodegeneration-associated mitochondrial proteins, CHCHD2 and CHCHD10–what distinguishes the two?
by: Aya Ikeda, et al.
Published: (2022-09-01)

Biological Stoichiometry Regulates Toxin Production in <i>Microcystis aeruginosa</i> (UTEX 2385)
by: Nicole D. Wagner, et al.
Published: (2019-10-01)

Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson’s disease with PARK2 mutation
by: Kei-ichi Ishikawa, et al.
Published: (2024-04-01)

Effect of Zinc on <i>Microcystis aeruginosa</i> UTEX LB 2385 and Its Toxin Production
by: Jose L. Perez, et al.
Published: (2020-01-01)

Characteristics and Attitudes of Men Using Anabolic Androgenic Steroids (AAS): A Survey of 2385 Men
by: Alex K. Bonnecaze MD, et al.
Published: (2020-12-01)

The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway.
by: Yuzuru Imai, et al.
Published: (2015-09-01)

Protective Effects of Hif2 Inhibitor PT-2385 on a Neurological Disorder Induced by Deficiency of Irp2
by: Jiaqi Shen, et al.
Published: (2021-10-01)

PB2385: CINOBUFAGIN PROMOTES APOPTOSIS OF DIFFUSE LARGE B LYMPHOMA CELLS BY INHIBITING UBIQUITINATION DEGRADATION OF TP53
by: Sanxiu He, et al.
Published: (2023-08-01)

Dynamic and redundant regulation of LRRK2 and LRRK1 expression
by: Dawson Ted M, et al.
Published: (2007-11-01)

LRRK2 kinase activity is dependent on LRRK2 GTP binding capacity but independent of LRRK2 GTP binding.
by: Jean-Marc Taymans, et al.
Published: (2011-01-01)

Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
by: Akio Mori, et al.
Published: (2020-05-01)

A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2
by: Naila Kuhlmann, et al.
Published: (2020-08-01)

Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson’s disease
by: Fukae, Jiro, et al.
Published: (2015)

Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2
by: Iqra Nazish, et al.
Published: (2023-12-01)

Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
by: Shijie Wang, et al.
Published: (2017-11-01)

First report of a Japanese family with spinocerebellar ataxia type 10: The second report from Asia after a report from China.
by: Hiroyuki Naito, et al.
Published: (2017-01-01)

Effective Perturbations of the Amplitude, Gating, and Hysteresis of <i>I</i><sub>K(DR)</sub> Caused by PT-2385, an HIF-2α Inhibitor
by: Hung-Tsung Hsiao, et al.
Published: (2021-08-01)

Computational analysis of the LRRK2 interactome
by: Claudia Manzoni, et al.
Published: (2015-02-01)

LRRK2 and Proteostasis in Parkinson’s Disease
by: María Dolores Pérez-Carrión, et al.
Published: (2022-06-01)